Stronger Diabetes Trials with Cyntegrity’s RACT
Cyntegrity’s Diabetes RACT helps teams identify key risks early, strengthen data quality, and run safer, smarter diabetes clinical trials.
Explore the ICH E6(R3) Interactive Visualizer
Explore how ICH E6(R3) reshapes GCP. The free, eyesON Interactive Visualizer transforms regulatory history into a clear, data-driven journey toward quality-by-design clinical trials.
CASE STUDY | Phase III Oncology: Targeted Risk-Based QA
For oncology study teams: see how ADAMAS applied Cyntegrity’s risk signals to focus QA in a global Phase III trial, supporting earlier actions and inspection readiness.
MHRA 2025: New Guidance for Medical Device Investigations
The MHRA’s latest guidance clarifies how medical device investigations are managed across Great Britain and Northern Ireland. Cyntegrity helps manufacturers stay inspection-ready with AI-enhanced RBQM tools that strengthen documentation, risk control, and overall data quality from design through post-market follow-up.